Sodium-glucose cotransporter 2, or SGLT2, inhibitors and glucagon-like peptide-1 receptor agonists lowered the risk for COPD exacerbation in adults with the disease and type 2 diabetes, researchers ...

The study reveals SGLT-2is are linked to fewer COPD exacerbations in type 2 diabetes, suggesting a need for further clinical ...

The following is a summary of “NTHi killing activity is reduced in COPD patients and is associated with a differential ...

In this randomized, controlled, multicenter, international trial, 7376 patients with moderate to very severe COPD who ... with more mild disease or those without previous exacerbations.

The results of this comparative effectiveness research study suggest that sodium-glucose cotransporter-2 inhibitors  and glucagon-like peptide-1 receptor agonists (GLP-1RAs) were associated with a ...

FET or huff FET; huff The FET involves carefully exhaling with the mouth and glottis open to generate mild dynamic ... Acute exacerbation of chronic obstructive pulmonary disease; COPD: Chronic ...

in adults with COPD was a statistically significant reduction in the annualised rate of moderate or severe exacerbations compared to placebo that GSK said was "clinically meaningful." In the study ...

A study was undertaken to investigate the sputum cell and cytokine characteristics of COPD when stable and during an exacerbation. METHODS Induced sputum samples from 57 patients with moderate to ...

Results: In patients with severe COPD (FEV 1 <50% predicted), the prevalence of depression was 25.0% compared with 17.5% in controls and 19.6% in patients with mild to moderate COPD. When the results ...

The ability to predict spirometry-defined COPD was significantly better when a modified lung function questionnaire score was ...

Researchers developed a new COPD-ES questionnaire for healthcare professionals to improve the management of stable chronic ...